Exome Sequencing for Isolated Congenital Hearing Loss: A Cost-Effectiveness Analysis
- 1 July 2021
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 131 (7), E2371-E2377
- https://doi.org/10.1002/lary.29356
Abstract
Objectives/Hypothesis To assess the relative cost-effectiveness of exome sequencing for isolated congenital deafness compared with standard care. Study Design Incremental cost-effectiveness and cost-benefit analyses were undertaken from the perspective of the Australian healthcare system using an 18-year time horizon. Methods A decision tree was used to model the costs and outcomes associated with exome sequencing and standard care for infants presenting with isolated congenital deafness. Results Exome sequencing resulted in an incremental cost of AU$1,000 per child and an additional 30 diagnoses per 100 children tested. The incremental cost-effectiveness ratio was AU$3,333 per additional diagnosis. The mean societal willingness to pay for exome sequencing was estimated at AU$4,600 per child tested relative to standard care, resulting in a positive net benefit of AU$3,600. Deterministic and probabilistic sensitivity analyses confirmed the cost-effectiveness of exome sequencing. Conclusions Our findings demonstrate the cost-effectiveness of exome sequencing in congenital hearing loss, through increased diagnostic rate and consequent improved process of care by reducing or ceasing diagnostic investigation or facilitating targeted further investigation. We recommend equitable funding for exome sequencing in infants presenting with isolated congenital hearing loss. Level of Evidence N/A. Laryngoscope, 2020Funding Information
- State Government of Victoria
This publication has 36 references indexed in Scilit:
- Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and GenomicsGenetics in Medicine, 2015
- “Is it Going to Hurt?”: The Impact of the Diagnostic Odyssey on Children and Their FamiliesJournal of Genetic Counseling, 2014
- Issues surrounding the health economic evaluation of genomic technologiesPharmacogenomics, 2013
- Diagnostic Application of Targeted Resequencing for Familial Nonsyndromic Hearing LossPLOS ONE, 2013
- Optical Histology: A Method to Visualize Microvasculature in Thick Tissue Sections of Mouse BrainPLOS ONE, 2013
- Do parental perceptions and motivations towards genetic testing and prenatal diagnosis for deafness vary in different cultures?American Journal of Medical Genetics Part A, 2012
- An audit of genetic testing in diagnosis of inherited retinal disorders: a prerequisite for gene-specific interventionClinical & Experimental Ophthalmology, 2009
- Simultaneous Multigene Mutation Detection in Patients With Sensorineural Hearing Loss Through a Novel Diagnostic Microarray: A New Approach for Newborn Screening Follow-upPEDIATRICS, 2006
- GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: A HuGE reviewGenetics in Medicine, 2002
- Applied Welfare Economics with Discrete Choice ModelsEconometrica, 1981